Breaking News, Promotions & Moves

PTC Therapeutics Appoints CSO, CTO

Pykett to lead research initiatives, Almstead responsible for manufacturing and supply chain

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Mark Pykett was named chief scientific officer of PTC Therapeutics, Inc. and Dr. Neil Almstead was appointed chief technical operations officer. “Achievement of our long-term strategy requires accelerating our research engine with our small molecule and gene therapy platforms as well as fostering our manufacturing expertise to focus on supplying the needs of our advancing gene therapy franchise,” said Stuart W. Peltz, Ph.D., chief executive officer of PTC Therapeutics. Dr. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters